Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial
Authors
- Thierry Roumeguère (ORCID: https://orcid.org/0000-0002-5377-8137)
- Ahmad Awada (ORCID: https://orcid.org/0000-0001-7412-9163)
- L. Staudacher
- Véronique Debien (ORCID: https://orcid.org/0000-0003-1165-925X)
- Sandrine Rorive
- Nuria Kotecki (ORCID: https://orcid.org/0000-0002-7753-230X)
- Emmanuel Seront (ORCID: https://orcid.org/0000-0003-4807-7472)
- Françoise Rothé (ORCID: https://orcid.org/0009-0003-2625-5642)
- Aurélien Carnot (ORCID: https://orcid.org/0000-0003-2933-4066)
- Vincent Vanhaudenarde
- Thibault Tricard (ORCID: https://orcid.org/0000-0002-2472-3575)
- Nieves Martínez Chanzá (ORCID: https://orcid.org/0000-0002-2340-7415)
- Jérémy Blanc
- Lieveke Ameye (ORCID: https://orcid.org/0000-0001-5153-1766)
- Brieuc Sautois (ORCID: https://orcid.org/0000-0002-0029-7735)
- Vinciane Casert
- Philippe Barthélémy (ORCID: https://orcid.org/0009-0006-3868-186X)
- Jean‐Christophe Fantoni
- Jan Van den Brande
Institutions
- Cliniques Universitaires Saint-Luc (BE)
- Institut Jules Bordet (BE)
- Erasmus Hospital (BE)
- Centre Hospitalier Universitaire de Lille (FR)
- CHU Ambroise Paré (BE)
- Institut de Cancérologie Strasbourg (FR)
- CHU Dinant Godinne UCL Namur (BE)
- Antwerp University Hospital (BE)
- Hôpital Saint Joseph (FR)
- Centre Oscar Lambret (FR)
- Centre Hospitalier Universitaire de Liège (BE)
- Hôpital Paris Saint-Joseph (FR)
- Hôpitaux Universitaires de Strasbourg (FR)
Publication Details
- Journal
- Journal for ImmunoTherapy of Cancer
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1136/jitc-2025-012045
- Citations
- 3
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.02